Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Curr Opin Nephrol Hypertens. 2016 Jan;25(1):50–58. doi: 10.1097/MNH.0000000000000187

Figure 1.

Figure 1

Direct and indirect effects of SGLT2 inhibition on the kidney and other organs, and the potential for beneficial cardiovascular effects and nephroprotection as well as unwanted side effects. PCKD, polycystic kidney disease.